Disease Awareness Ads Must Be Different, Distant From Branded Ads, FDA Says
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA is encouraging the use of disease awareness advertisements but warns that ads too similar or shown too close together with branded spots could result in product withdrawal.
You may also be interested in...
Guidance On Outdoor Promotion Will Formalize "Traditional" Approach – FDA
A draft guidance on outdoor promotion will formalize the Division of Drug Marketing, Advertising & Communications' "traditional" approach to reviewing the advertisements, Director Thomas Abrams said
Guidance On Outdoor Promotion Will Formalize "Traditional" Approach – FDA
A draft guidance on outdoor promotion will formalize the Division of Drug Marketing, Advertising & Communications' "traditional" approach to reviewing the advertisements, Director Thomas Abrams said
Pfizer Seeks Better Definition Of FDA Limits On Ad Similarity, Proximity
Pfizer is asking FDA to clarify how different and how distant help-seeking ads must be from direct-to-consumer full product ads to comply with the agency's disease awareness draft guidance